The FDA approves Aduhelm for the treatment of early Alzheimer's disease. Aduhelm targets brain plaque formation to slow the rate of cognitive decline.

Fixing one piece of the healthcare puzzle is encouraging - but is it transformational? Here are 10 things we can consider to make things better.

The dilemma and stress of a healthcare diagnosis are something everyone can experience, and insurance plays a significant role.

One current theory is that this type of Alzheimer’s may be familial, but a similar form is found in those with Down Syndrome. Estimates suggest that 50 percent or more of people with Down syndrome will develop dementia due to Alzheimer’s disease as they age.